D'Alonzo A - Search Results

1

Adjuvant hypofractionated radiotherapy with weekly concomitant boost for women with early breast cancer: the clinical experience at Genoa university.

Corvò R, Ricchetti F, Doino D, Torielli P, Agostinelli S, Cavagnetto F, Giannelli F, D'Alonzo A, Vagge S, Belgioia L, Guenzi M. Corvò R, et al. Anticancer Res. 2010 Nov;30(11):4749-53. Anticancer Res. 2010. PMID: 21115935

2

A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects.

Guenzi M, Vagge S, Azinwi NC, D'Alonzo A, Belgioia L, Garelli S, Gusinu M, Corvò R. Guenzi M, et al. Radiat Oncol. 2010 Nov 22;5:111. doi: 10.1186/1748-717X-5-111. Radiat Oncol. 2010. PMID: 21092219 Free PMC article. Clinical Trial.

3

Preliminary experience using oncoplastic techniques of reduction mammaplasty and intraoperative radiotherapy: report of 2 cases.

Franchelli S, Meszaros P, Guenzi M, Corvó R, Pertile D, Massa M, Belgioia L, D'Alonzo A, Cafiero F, Santi P. Franchelli S, et al. Aesthetic Plast Surg. 2011 Dec;35(6):1180-3. doi: 10.1007/s00266-011-9735-7. Epub 2011 May 10. Aesthetic Plast Surg. 2011. PMID: 21556986

4

Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during chemotherapy for early breast cancer.

Levaggi A, De Maria A, Dozin B, Iacono G, Bighin C, Giraudi S, Lambertini M, D'Alonzo A, Poggio F, Pronzato P, Del Mastro L. Levaggi A, et al. Anticancer Res. 2014 Jul;34(7):3715-20. Anticancer Res. 2014. PMID: 24982392

5

Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients.

Del Mastro L, Lambertini M, Bighin C, Levaggi A, D'Alonzo A, Giraudi S, Pronzato P. Del Mastro L, et al. Expert Rev Anticancer Ther. 2012 Nov;12(11):1391-405. doi: 10.1586/era.12.107. Epub 2012 Oct 16. Expert Rev Anticancer Ther. 2012. PMID: 23072512 Review.

6

Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis.

Poggio F, Ceppi M, Lambertini M, Bruzzi P, Ugolini D, Bighin C, Levaggi A, Giraudi S, D'Alonzo A, Vaglica M, Blondeaux E, Sertoli MR, Pronzato P, Del Mastro L. Poggio F, et al. Breast. 2017 Jun;33:104-108. doi: 10.1016/j.breast.2017.03.011. Epub 2017 Mar 27. Breast. 2017. PMID: 28360014 Review.

7

T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study.

Conte B, Fabi A, Poggio F, Blondeaux E, Dellepiane C, D'Alonzo A, Buono G, Arpino G, Magri V, Naso G, Presti D, Mura S, Fontana A, Cognetti F, Molinelli C, Pastorino S, Bighin C, Miglietta L, Boccardo F, Lambertini M, Del Mastro L; Gruppo Italiano Mammella (GIM) study group. Conte B, et al. Among authors: d alonzo a. Clin Breast Cancer. 2020 Apr;20(2):e181-e187. doi: 10.1016/j.clbc.2019.09.001. Epub 2019 Nov 14. Clin Breast Cancer. 2020. PMID: 31735691

8

Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study.

Bighin C, Dozin B, Poggio F, Ceppi M, Bruzzi P, D'Alonzo A, Levaggi A, Giraudi S, Lambertini M, Miglietta L, Vaglica M, Fontana V, Iacono G, Pronzato P, Del Mastro L. Bighin C, et al. Oncotarget. 2017 Jul 4;8(27):44800-44810. doi: 10.18632/oncotarget.14735. Oncotarget. 2017. PMID: 28108743 Free PMC article.

9

Trastuzumab-related cardiotoxicity in patients with nonlimiting cardiac comorbidity.

Martinello R, Becco P, Vici P, Airoldi M, Del Mastro L, Garrone O, Barone C, Pizzuti L, D'Alonzo A, Bellini E, Milani A, Bonzano A, Montemurro F. Martinello R, et al. Among authors: d alonzo a. Breast J. 2019 May;25(3):444-449. doi: 10.1111/tbj.13240. Epub 2019 Apr 1. Breast J. 2019. PMID: 30932296

10

Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.

Boero S, Morabito A, Banelli B, Cardinali B, Dozin B, Lunardi G, Piccioli P, Lastraioli S, Carosio R, Salvi S, Levaggi A, Poggio F, D'Alonzo A, Romani M, Del Mastro L, Poggi A, Pistillo MP. Boero S, et al. J Transl Med. 2015 Oct 8;13:324. doi: 10.1186/s12967-015-0680-0. J Transl Med. 2015. PMID: 26450443 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page